Steeplechase Cancer Center — Somerville, New Jersey

Steeplechase Cancer Center is a clinical research site located in Somerville, New Jersey, United States 08876.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Steeplechase Cancer Center has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Multiple Myeloma, Breast Cancer, Early-Onset.

Sponsors: Celgene, Rutgers, The State University of New Jersey, Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Steeplechase Cancer Center?

Steeplechase Cancer Center has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Steeplechase Cancer Center conducted?

Steeplechase Cancer Center has 4 clinical trials on record, with 2 currently active. Their work covers Chronic Lymphocytic Leukemia, Multiple Myeloma, Breast Cancer, Early-Onset.

Is Steeplechase Cancer Center accredited by Crixeo Health?

Steeplechase Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Steeplechase Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.